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Abstract
Background: TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene has been reported to be
associated with serum high-density lipoprotein cholesterol (HDL-C) levels and longevity in several populations, but
controversial results also arose probably due to racial/ethnic diversity. Bama is a remote and mountainous county
located in the northwest of Guangxi, People’s Republic of China, which has been well known for its longevity for
centuries. The current study was to investigate the possible association of CETP TaqIB polymorphism with serum
lipid levels and longevity in the Bama Zhuang population.
Methods: The CETP TaqIB genotypes were determined by polymerase chain reaction and restriction fragment length
polymorphism in 523 long-lived inhabitants (long-lived group, LG; aged 90-107 years) and 498 healthy controls without
longevity family history (non-long-lived group, non-LG; aged 40-69 years) residing in Bama County.
Results: The levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density
lipoprotein cholesterol (LDL-C) were higher but TG, HDL-C/LDL-C ratio and the prevalence of dyslipidemia were
lower in LG than in non-LG (P < 0.001 for all). There were no differences in the allelic and genotypic frequencies
between the two groups (P > 0.05). Serum HDL-C levels and HDL-C/LDL-C ratio in LG were different among the
genotypes (P < 0.01 for each), the subjects with B2B2 and B1B2 genotyes had higher HDL-C levels and HDL-C/LDL-
C ratio than the subjects with B1B1genotye, whereas the levels of TC and HDL-C in non-LG were different among/
between the genotypes (P < 0.01 for each), the B2 allele carriers had lower TC and higher HDL-C levels than the
B2 allele noncarriers. Serum TG and HDL-C levels and HDL-C/LDL-C ratio were correlated with genotypes in LG,
whereas serum TC and HDL-C levels were associated with genotypes in non-LG (P < 0.05-0.001).
Conclusions: The association of CETP TaqIB polymorphism and serum lipid profiles is different between LG and
non-LG in the Chinese Bama Zhuang population. CETP TaqIB polymorphism might be one of the longevity-related
genetic factors in this population.
Introduction
Cholesterol plays an essential physiological role in
humans. It is mainly synthesized and esterified by the liver
and then is secreted from the liver into plasma as very low
density lipoprotein (VLDL), which gets converted to low
density lipoprotein (LDL). In contrast, reverse cholesterol
transport (RCT) mediates the conveyance of free unesteri-
fied cholesterol mobilized from peripheral cells and des-
tined for disposal by the liver. In this process, cholesteryl
ester transfer protein (CETP), a 74-kDa hydrophobic gly-
coprotein, facilitates the transfer of cholesterol ester from
high density lipoprotein (HDL) to apolipoprotein (Apo)
B-containing lipoproteins including VLDL and LDL, for
disposal via the LDL receptor pathway in the liver, and of
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any medium, provided the original work is properly cited.triglyceride (TG) in the opposite direction in plasma [1,2].
Remarkably, these rationales indicate that CETP plays a
significant role in the modulation of cholesterol.
In humans, CETP is expressed predominantly in the
liver, spleen, and adipose tissue [1]. Detectable levels of
CETP can also be seen in the small intestine, adrenal
g l a n d s ,h e a r t ,k i d n e y s ,o rs k e l e t a lm u s c l e[ 3 ] .T h eg e n e
encoding CETP consists of 16 exons and 15 introns
encompassing 25 kb on chromosome 16q12-21 adjacent
to the lecithin-cholesterol acyltransferase gene [4]. To
date, a number of common polymorphisms and rare var-
iants at the CETP gene locus, such as I405V, D442G,
I14A, A373P, R451Q, promoter polymorphism (Y629A/
C, Y1337C/T and Y971G/A), which cause depletion of
CETP activity and consequently high high-density lipo-
protein cholesterol (HDL-C) in plasma, have been
described across populations [5-8]. One of these common
polymorphisms is TaqIB, a silent base change affecting
the 277th nucleotide in the first intron of the CETP gene
[4]. The B2 allele, absence of the TaqI restriction site, has
been found to be associated with elevated plasma HDL-C
level and reduced plasma CETP mass and activity and
coronary heart disease (CHD) risk [9-12], and accord-
ingly to be associated with longer life expectancy [13,14].
This hypothesis is further supported by the fact that high
HDL-C levels are often observed in healthy elderly aged
85 and above [13,15]. However, inconsistent findings also
arose in different studies, e.g., a positive association of
HDL-C levels with increased CHD risk has been reported
[16]; not all CETP deficiencies with high HDL-C levels
are correlated with longevity [17]. These controversial
results suggest that the roles of CETP gene variations in
longevity appear much more complex than expected and
need further elucidation.
Bama is a remote and mountainous county located in
the northwest of Guangxi, People’s Republic of China. It
has been well known for its longevity for centuries. The
population size and centenarian rate in Bama County are
around 240,000 and 30/100,000 respectively, according to
the National Population Census of China in the past dec-
ades [18,19]. Although a number of studies involving nat-
ural environment, dietary habit, socioeconomic status
and genetic background have been conducted for decades
[19-22], the underlying mechanisms of the longevity in
this county are still unknown. Genetically, the majority
(> 85%) of the inhabitants living in Bama County belong
to the north branch of Zhuang ethnic group. Zhuang is
the largest minority in China with a total population of
15 millions [23,24]. Long-term geographic and social iso-
lation as well as inbreeding result in both cultural and
genetic homogeneity of Bama Zhuang branch, and there-
fore Bama Zhuang has become a useful subgroup for
population genetic studies.W eh a v ei n i t i a t e dt h eB a m a
Longevity Genetic Study (BLGS) since late 1998. Several
genetic polymorphisms such as human leukocyte antigen
(HLA), ApoE, p53, and transforming growth factor-b1
(TGF-b1) genes and the haplotypes of mitochondria
DNA [19,25-29] have been shown difference between
long-lived group (LG) and non-long-lived group (non-
LG), indicating that Bama long-lived individuals may
have favorable genetic background for their survivals.
Therefore, the aim of the present study was to determine
the TaqIB polymorphism of CETP gene and its associa-
tion with serum lipid levels and longevity in the Chinese
Bama Zhuang population.
Materials and methods
Study population
A total of 523 long-lived subjects (339 females and 184
males, LG) with exceptional longevity residing in Bama
County, Guangxi, People’sR e p u b l i co fC h i n aw e r e
recruited to participate in the study, which was con-
ducted from 2008 to 2011. The ages of the subjects ran-
ged from 90 to 107 years, with an average age of 93.38 ±
3.09 years. The ages were defined by dates of birth as sta-
ted on identity cards. During the same period, a total of
498 healthy participants (253 males and 245 females,
non-LG) without longevity family history were also ran-
domly selected from the same area. The average age of
the participants was 53.12 ± 8.86 years (range, 40-69
years). All study subjects were unrelated and belong to
Zhuang ethnic group. They have been living in Bama
rural area and doing farm work lifelong. All subjects were
essentially healthy and had no evidence of any chronic ill-
ness, including hepatic, renal, or thyroid. The participants
with a history of myocardial infarction, stroke, diabetes
were also excluded. The participants were not taking
medications known to affect serum lipid levels such as
statins or fibrates, beta-blockers, diuretics, or hormones.
The current study was approved by the Ethics Committee
of Guangxi Medical University. Informed consent was
obtained from all subjects after they received a full expla-
nation of the study.
Epidemiological survey
Information on demography and lifestyle factors was col-
lected with standardized questionnaires. The physical
examination included blood pressure, body height, body
weight, waist circumference, and body mass index (BMI)
was calculated as weight in kilograms divided by the
square of height in meters (kg/m
2). Sitting blood pressure
was obtained 3 times, using a standard mercury sphyg-
momanometer with the subject resting for at least 5 min-
utes, and the average of the 3 measurements was used for
the level of blood pressure. Systolic blood pressure was
determined by the first Korotkoff sound; and diastolic
blood pressure, by the fifth Korotkoff sound. Hyperten-
sion was defined as an average systolic blood pressure of
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pressure of 90 mmHg or greater, and/or self-reported
pharmacological treatment for hypertension within the 2
weeks prior to the interview [30]. Normal weight, over-
weight, and obesity were defined as BMI < 24, 24 to 28,
and > 28 kg/m
2, respectively [31].
Biochemical analysis
A venous blood sample of 8 mL was drawn from each
subject after an overnight fasting. 4 mL of the sample was
collected in a glass tube for serum lipid determination.
The remaining sample was transferred to a tube with
anticoagulant solution (4.80 g/L citric acid, 14.70 g/L glu-
cose, and 13.20 g/L trisodium citrate) for DNA extraction.
The levels of serum total cholesterol (TC), TG, HDL-C,
and LDL-C in samples were determined by enzymatic
methods with commercially available kits, Tcho-1, TGLH
(Randox Laboratories Ltd, Crumlin, Antrim, United King-
dom), Cholestest N HDL, and Cholestest LDL (Daiichi
Pure Chemicals Co, Ltd., Tokyo, Japan), respectively. All
determinations were performed by standard automated
methods with a biochemical analyzer (Type 7170A; Hita-
chi Ltd, Tokyo, Japan) at the Clinical Science Experiment
Center of the First Affiliated Hospital, Guangxi Medical
University. The normal ranges of serum TC, TG, HDL-C,
and LDL-C levels in the Center were 3.10-5.17, 0.56-1.70,
0.91-1.81, and 1.70-3.20 mmol/L, respectively. The indivi-
duals with TC > 5.17 mmol/L and/or TG > 1.70 mmol/L
were defined as hyperlipidemic [32].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leuko-
cytes by standard methods [33]. Genotyping of the CETP
TaqIB was performed as described previously [34] basing
on the protocol introduced by Fumeron et al. [35].
Briefly, a 535 bp fragment in intron 1 of the CETP gene
was amplified by polymerase chain reaction (PCR), with
use of the following primers: F: 5’-CACTAGCCCAGA-
GAGAGGAGTGCC-3’ and R: 5’-CTGAGCCCAGCCG-
CACACTAA-3’. (Sangon Biotech Co., Ltd., Shanghai,
People’s Republic of China). PCR was performed in a
volume of 20 μL containing 200 ng of genomic DNA,
plus 10 μLo fTaq MasterMix (Beijing CoWin Bioscience
Co., Ltd. People’s Republic of China), 6.25 μM (1.0 μL) of
each primer, 7 μLd d H 2O and 1 U of DNA polymerase
(Takara Biotechnology Co, Ltd, Dalian, People’s Republic
of China). The cycle profile was as follows: predenatura-
tion at 94°C for 2 min, followed by 30 cycles of denatura-
tion at 94°C for 30 s, annealing at 63°C for 30 s, and
extension at 72°C for 30 s, with a final extension at 72°C
for 5 min. The PCR products (8 μL) were digested with
TaqI (0.2 U) restriction endonuclease (Takara Biotech-
nology Co, Ltd, Dalian, People’s Republic of China) at
65°C for 4 h, and the fragments were separated by
electrophoresis in a 2% agarose gel for 45 min at 80 V.
The target DNA fragments were 174- and 361-bp for the
B1 allele and 535 bp for the B2 allele. The genotypes
were identified and named according to the presence or
absence of the enzymatic restriction sites, i.e. bands at
535-, 361-, and 174-bp for B1B2 heterozygotic genotype,
361- and 174-bp for B1B1 homozygotic genotype, and
535 bp for B2B2 homozygotic genotype. Laboratory tech-
nicians were masked to clinical and biochemical data.
Statistical analyses
Levels of the quantitative variables are presented as
mean ± SD (serum TG levels are presented as medians
and interquartile ranges). Hardy-Weinberg equilibrium
was computed for the expected genotype distribution.
Allelic and genotypic frequencies were calculated
directly. Comparison of mean values of general charac-
teristics between study groups was performed with the
student unpaired t test and One-way ANOVA test. The
statistical evaluation for the categorical variables was
b a s e do nt h ec a l c u l a t i o no ft he chi-square and Fisher’s
exact criteria. The association of CETP TaqIB genotypes
with serum lipid variables was tested by analysis of cov-
ariance. In order to assess the association of serum lipid
levels with genotypes (B1B1 = 1, B1B2 = 2 and B2B2 =
3), multivariable linear regression analyses with stepwise
modeling were also performed in the combined popula-
tion of LG and non-LG, LG, non-LG; respectively. All
tests were two-sided and P-values of 0.05 were consid-
ered significant. Data were analyzed using the statistical
software package SPSS 13.0 (SPSS Inc, Chicago, IL).
Results
General characteristics and serum lipid levels
A summary of demographic, clinical, and biochemical
characteristics of LG and non-LG is provided in Table 1.
BMI was lower in LG as compared to non-LG (P <0 . 0 0 1 ) .
The levels of systolic blood pressure and diastolic blood
pressure were significantly higher in LG than in non-LG
(P < 0.001 for all). The levels of TC, HDL-C, and LDL-C
were markedly higher, while TG, HDL-C/LDL-C ratio as
well as the prevalence of dyslipidemia were lower in LG as
compared with non-LG (P < 0.001 for all).
Genotypic and allelic frequencies
The CETP TaqIB genotype and allele frequencies are
shown in Table 2. The dominant allele was B1, and the
dominant genotypes were B1B2 and B1B1 in both groups.
Homozygotic B2B2 genotype only accounted for approxi-
mately 10% in the studied participants. No significant dif-
ference was observed in the distribution of genotypes and
alleles between the two groups (both P > 0.05), albeit the
frequency of B2 allele was slightly higher in the longevity
group as compared with the counterparts.
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As shown in Table 3, the levels of HDL-C and the ratio
of HDL-C to LDL-C in LG were different among the
genotypes (P < 0.01 for each), the subjects with B2B2
and B1B2 genotyes had higher HDL-C levels and HDL-
C/LDL-C ratio than the subjects with B1B1genotye,
whereas the levels of TC and HDL-C in non-LG were
different among/between the genotypes (P <0 . 0 1f o r
each), the B2 allele carrier sh a dl o w e rT Ca n dh i g h e r
HDL-C levels than the B2 allele noncarriers. When the
association of CETP TaqIB polymorphism and serum
lipid levels was stratified by gender, we found that
serum TC, TG, and HDL-C levels in the combined
population were different among the genotypes in males
(P < 0.05-0.001), and HDL-C and LDL-C levels were dif-
ferent among the genotypes in females (P <0 . 0 1a n d
P < 0.05; respectively; Table 4). Serum HDL-C levels in
LG were different among the genotypes in males (P <
0.05) but not in females (Table 5). Serum HDL-C levels
in non-LG were different among the genotypes in males
(P < 0.001), and TC, HDL-C and LDL-C levels were dif-
ferent among the genotypes in females (P < 0.05-0.001;
Table 6).
Correlation between serum lipid parameters and
genotypes
Multiple linear regression analysis showed that serum
TG and HDL-C levels and HDL-C/LDL-C ratio were
correlated with genotypes in LG, whereas serum TC and
HDL-C levels were associated with genotypes in non-LG
(P < 0.05-0.001; Table 7).
Discussion
TaqIB is one of the common polymorphisms of the CETP
gene. In the current study, the overall frequency of B2
allele was 0.372 (0.384 in LG and 0.345 in non-LG), simi-
lar to our previous finding in Hei Yi Zhuang, another
Zhuang subgroup resides in Napo, a county bordering
northwest Vietnam [34,36], and to the result from differ-
ent populations, such as Han Chinese (0.39), Vietnamese
(0.34), and Korean (0.36) [37-39], but lower than that in
Caucasians (0.40-0.64) [14,40], Jewishes and Japaneses
[17,41,42]. The considerable high frequency of B2 muta-
tion across populations worldwide appears to imply that
the origin of B2 can at least be traced back long before the
differentiation of major ethnic groups for some selective
reasons. We did not observe significant difference in geno-
typic and allelic frequencies of CETP TaqIB polymorph-
ism between the two groups; this was in agreement with
those of the Japanese centenarian study [13,17]. However,
there was a trend that the frequencies of B1 allele and
B1B1 genotype in long-lived individuals was slightly lower
than those in non-long-lived subjects, or conversely, the
B2 allele tended to enrich in the elderly old. This observa-
tion seems to imply that the evolution of B2 allele may be
favorable for the survivals of modern human beings whose
living environment and dietary structure have been chan-
ging tremendously, at least in Bama area.
Table 1 Clinical characteristics and serum lipid profiles between LG and non-LG
Paramenter LG (n = 523) non-LG (n = 498) t (c
2) P
Age (years) 93.38 ± 3.06 53.12 ± 8.86 96.088 0.000
Gender (M/F) 184/339 253/245 25.428 0.000
Body mass index (kg/m
2) 20.22 ± 3.52 22.14 ± 3.67 -8.521 0.000
Systolic blood pressure (mmHg) 166.14 ± 28.04 131.31 ± 20.23 22.844 0.000
Diastolic blood pressure (mmHg) 89.33 ± 13.48 85.24 ± 11.43 5.240 0.000
Total cholesterol (mmol/L) 5.13 ± 1.01 4.87 ± 0.96 4.177 0.000
Triglyceride (mmol/L) 0.97 (0.47) 1.08 (0.86) -3.256 0.001
HDL-C (mmol/L) 1.60 ± 0.35 1.51 ± 0.29 4.698 0.000
LDL-C (mmol/L) 3.04 ± 0.87 2.69 ± 0.89 6.427 0.000
HDL-C/LDL-C ratio 0.57 ± 0.24 0.67 ± 0.59 -3.466 0.001
Dyslipidemia [n (%)] 66(12.62) 94(18.88) -7.555 0.000
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range),
the difference between the two groups was determined by the Wilcoxon-Mann-Whitney test.
Table 2 Genotype and allele frequencies of the CETP TaqIB polymorphism in LG and non-LG [n (%)]
Groups n Genotype Allele
B1B1 B1B2 B2B2 B1 B2
LG 523 187 (35.8) 270 (51.6) 66 (12.6) 644 (61.6) 402 (38.4)
Non-LG 498 206 (41.4) 240 (48.2) 52 (10.4) 652 (65.5) 344 (34.5)
c
2 - 3.734 3.336
P - 0.155 0.068
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risk factor for CHD [43]. A growing body of evidences
demonstrate that elevated levels of HDL-C may reduce
CHD risk and thus contribute to longer life expectancy
[13]. We also found higher HDL-C and LDL-C levels in
the long-lived subjects as compared to general popula-
tions. Moreover, this raised HDL-C was associated with
B2 allele and B2B2 genotype, which was consistent with
Table 3 Comparison of serum lipid levels among the genotypes between the two groups
Group Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
HDL-C
/LDL-C
LG B1B1 187 5.16 ± 1.00 1.03(0.59) 1.54 ± 0.31
b 3.11 ± 0.84
b 0.53 ± 0.17
B1B2 270 5.09 ± 1.02 0.95(0.44) 1.63 ± 0.37
a 3.01 ± 0.89
b 0.60 ± 0.26
B2B2 66 5.17 ± 0.99 0.97(0.41) 1.67 ± 0.35
a 2.99 ± 0.88
b 0.62 ± 0.28
F - - 0.283 3.845 4.868 0.867 6.592
P - - 0.753 0.146 0.008 0.421 0.001
B1B1 187 5.16 ± 1.00 1.03(0.59) 1.54 ± 0.31 3.11 ± 0.84 0.53 ± 0.17
B1B2/B2B2 336 5.11 ± 1.01 0.95(0.43) 1.64 ± 0.37 3.00 ± 0.89 0.60 ± 0.27
F - - 0.247 -1.779 10.279 1.785 12.432
P - - 0.620 0.075 0.001 0.182 0.000
Non-LG B1B1 206 4.79 ± 0.96 1.12(0.84) 1.45 ± 0.29 2.64 ± 0.90 0.70 ± 0.82
B1B2 240 4.92 ± 0.93 1.04(0.84) 1.53 ± 0.28
a 2.76 ± 0.90 0.64 ± 0.36
B2B2 52 4.95 ± 1.09 1.27(1.11) 1.64 ± 0.28
a 2.53 ± 0.81 0.74 ± 0.33
F - - 1.288 3.636 10.681 1.950 0.875
P - - 0.277 0.162 0.000 0.143 0.418
B1B1 206 4.79 ± 0.96 1.12(0.84) 1.45 ± 0.29 2.64 ± 0.90 0.70 ± 0.82
B1B2/B2B2 292 4.95 ± 0.96 1.06(0.88) 1.54 ± 0.29 2.73 ± 0.89 0.66 ± 0.36
F - - 4.713 -1.007 12.514 1.732 0.596
P - - 0.030 0.314 0.000 0.189 0.441
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was
presented as median (interquartile range). The difference among/between the genotypes was determined by the Kruskal-Wallis test or Wilcoxon-Mann-Whitney
test
a P < 0.05 in comparison with B1B1 genotype of same group;
bP < 0.05 in comparison with the same genotype of non-LG
Table 4 Comparison of clinical characteristics and serum lipid levels among the genotypes stratified by gender in
overall population
Parameter B1B1 B1B2 B2B2 FP
Male/n 166 224 47 - -
Age (years) 70.15 ± 21.11 68.85 ± 21.37 69.62 ± 23.38 0.177 0.838
Body mass index (kg/m
2) 21.48 ± 3.35 21.58 ± 3.43 21.17 ± 4.04 0.285 0.752
Systolic blood pressure (mmHg) 146.767 ± 26.80 142.51 ± 27.92 144.98 ± 26.29 1.169 0.312
Diastolic blood pressure (mmHg) 88.76 ± 12.64 85.90 ± 11.89 88.04 ± 14.55 2.615 0.074
Total cholesterol (mmol/L) 4.937 ± 1.09 4.88 ± 1.00 5.36 ± 1.12 4.237 0.015
Triglyceride (mmol/L) 1.08(0.67) 0.95(0.78) 1.18(0.74) 7.329 0.026
HDL-C (mmol/L) 1.47 ± 0.30 1.57 ± 0.33 1.71 ± 0.36 10.803 0.000
LDL-C (mmol/L) 2.85 ± 0.96 2.74 ± 0.94 2.86 ± 0.93 0.788 0.455
HDL-C/LDL-C 0.66 ± 0.89 0.67 ± 0.34 0.68 ± 0.33 0.010 0.990
Female/n 227 286 71 - -
Age (years) 73.93 ± 21.91 78.76 ± 19.30 79.56 ± 18.62 4.249 0.015
Body mass index (kg/m
2) 21.24 ± 4.52 20.47 ± 3.30 21.59 ± 3.70 3.777 0.023
Systolic blood pressure (mmHg) 150.42 ± 29.39 154.15 ± 33.03 154.17 ± 32.08 0.972 0.379
Diastolic blood pressure (mmHg) 88.18 ± 12.45 86.59 ± 13.09 88.35 ± 12.78 1.188 0.305
Total cholesterol (mmol/L) 4.99 ± 0.92 5.12 ± 0.96 4.88 ± 0.93 2.392 0.092
Triglyceride (mmol/L) 1.07(0.80) 1.00(0.49) 1.00(0.60) 2.739 0.254
HDL-C (mmol/L) 1.50 ± 0.30 1.59 ± 0.35 1.62 ± 0.29 5.739 0.003
LDL-C (mmol/L) 2.87 ± 0.85 3.02 ± 0.86 2.74 ± 0.84 3.810 0.023
HDL-C/LDL-C 0.57 ± 0.23 0.58 ± 0.29 0.66 ± 0.29 2.954 0.053
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range),
the difference among the genotypes was determined by the Kruskal-Wallis Test.
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[17,47]. It is widely accepted that B2 allele carriers exhi-
bit lower CETP levels and/or activity, leading to a dys-
function of the reverse cholesterol transport, causing an
accumulation of cholesterol ester in HDL style and thus
increasing the levels of HDL-C. The mechanism
by which TaqIB polymorphism may affect CETP activity
or HDL-C levels is not well known. Because this
Table 5 Comparison of clinical characteristics and serum lipid Levels among genotypes stratified by gender in LG
Parameter B1B1 B1B2 B2B2 FP
Male/n 70 91 23 - -
Age (years) 93.61 ± 3.43 93.17 ± 2.68 92.61 ± 2.73 1.081 0.341
Body mass index (kg/m
2) 20.82 ± 3.70 20.30 ± 3.30 20.30 ± 5.05 0.426 0.654
Systolic blood pressure (mmHg) 164.79 ± 26.08 162.59 ± 27.50 161.22 ± 23.48 0.213 0.808
Diastolic blood pressure (mmHg) 88.60 ± 13.55 89.14 ± 13.73 88.70 ± 13.65 0.034 0.967
Total cholesterol (mmol/L) 4.97 ± 1.07 4.96 ± 1.09 5.30 ± 1.05 0.96 0.385
Triglyceride (mmol/L) 0.93(0.37) 0.91(0.32) 1.03(0.41) 5.925 0.052
HDL-C (mmol/L) 1.52 ± 0.33 1.65 ± 0.39 1.73 ± 0.44 3.768 0.025
LDL-C (mmol/L) 2.98 ± 0.93 2.89 ± 0.94 3.01 ± 0.96 0.244 0.784
HDL-C/LDL-C 0.66 ± 0.89 0.67 ± 0.34 0.68 ± 0.33 0.010 0.990
Female/n 117 179 43 - -
Age (years) 94.07 ± 3.30 92.99 ± 2.86 93.65 ± 3.28 4.432 0.013
Body mass index (kg/m
2) 19.86 ± 3.25 19.89 ± 3.24 21.44 ± 4.25 3.970 0.020
Systolic blood pressure (mmHg) 167.16 ± 27.44 167.87 ± 29.84 168.47 ± 28.78 0.038 0.962
Diastolic blood pressure (mmHg) 91.08 ± 13.38 88.04 ± 13.40 91.84 ± 13.21 2.526 0.082
Total cholesterol (mmol/L) 5.27 ± 0.94 5.16 ± 0.98 5.10 ± 0.96 0.645 0.525
Triglyceride (mmol/L) 1.09(0.76) 1.00(0.51) 0.95(0.41) 2.923 0.232
HDL-C (mmol/L) 1.55 ± 0.30 1.62 ± 0.37 1.64 ± 0.30 1.603 0.203
LDL-C (mmol/L) 3.19 ± 0.77 3.07 ± 0.86 2.97 ± 0.84 1.255 0.287
HDL-C/LDL-C 0.57 ± 0.23 0.58 ± 0.29 0.66 ± 0.29 2.954 0.053
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range),
the difference among the genotypes was determined by the Kruskal-Wallis Test.
Table 6 Comparison of clinical characteristics and serum lipid levels among genotypes stratified by gender in non-LG
Parameter B1B1 B1B2 B2B2 FP
Male/n 96 133 24 - -
Age (years) 53.04 ± 8.00 52.21 ± 8.95 47.58 ± 7.11 4.044 0.019
Body mass index (kg/m
2) 21.96 ± 2.99 22.46 ± 3.25 22.00 ± 2.62 0.808 0.447
Systolic blood pressure (mmHg) 133.63 ± 18.41 128.77 ± 18.25 129.42 ± 18.40 2.022 0.135
Diastolic blood pressure (mmHg) 88.88 ± 11.99 83.68 ± 9.89 87.42 ± 15.63 6.040 0.003
Total cholesterol (mmol/L) 4.90 ± 1.11 4.82 ± 0.94 5.43 ± 1.21 3.531 0.031
Triglyceride (mmol/L) 1.22(0.76) 1.16(1.02) 1.28(1.38) 3.231 0.199
HDL-C (mmol/L) 1.44 ± 0.27 1.52 ± 0.27 1.69 ± 0.27 8.180 0.000
LDL-C (mmol/L) 2.76 ± 0.99 2.63 ± 0.93 2.71 ± 0.90 0.485 0.616
HDL-C/LDL-C 0.75 ± 1.16 0.68 ± 0.37 0.72 ± 0.34 0.196 0.822
Female/n 110 107 28 - -
Age (years) 52.51 ± 9.27 54.95 ± 8.56 57.93 ± 8.97 4.792 0.009
Body mass index (kg/m
2) 22.71 ± 5.18 21.45 ± 3.18 21.82 ± 2.70 2.562 0.079
Systolic blood pressure (mmHg) 132.62 ± 19.22 131.21 ± 24.28 132.21 ± 23.53 0.112 0.894
Diastolic blood pressure (mmHg) 85.09 ± 10.59 84.15 ± 12.22 83.00 ± 10.15 0.446 0.641
Total cholesterol (mmol/L) 4.69 ± 0.79 5.05 ± 0.92 4.55 ± 0.80 6.635 0.002
Triglyceride (mmol/L) 1.01(0.95) 0.98(0.45) 1.18(1.41) 0.975 0.614
HDL-C (mmol/L) 1.45 ± 0.30 1.54 ± 0.30 1.60 ± 0.28 3.788 0.024
LDL-C (mmol/L) 2.54 ± 0.80 2.93 ± 0.84 2.38 ± 0.70 8.591 0.000
HDL-C/LDL-C 0.64 ± 0.28 0.60 ± 0.35 0.74 ± 0.33 2.270 0.106
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range),
the difference among the genotypes was determined by the Kruskal-Wallis Test.
Pan et al. Lipids in Health and Disease 2012, 11:26
http://www.lipidworld.com/content/11/1/26
Page 6 of 9p o l y m o r p h i s ml o c a t e di na ni n t r o no ft h eC E T Pg e n e
which is unlikely to exhibit any functional effect. Given
the reported associations of the B2 allele with increased
CETP mass and/or activity, the most putative explana-
tion is that this polymorphism is in linkage disequili-
brium with some unknown functional mutations in the
regulatory region of the CETP gene which might inter-
act with each other to determine the HDL-C levels
[45,48].
Some investigators suggested that TaqIB polymorph-
isms were solely associated with HDL-C levels, without
being influenced by factors such as smoking, alcohol
consumption and BMI [49], but most researchers
believed that the association between TaqIB polymorph-
isms and HDL-C levels might be greatly affected by
dietary habits, smoking, obesity, gender, and ethnic
groups, etc. [34,50-52]. In the present study, we also
showed that the association of CETP TaqIB polymorph-
ism and serum lipid profiles is different between LG and
non-LG, or between males and females in the Chinese
Bama Zhuang population. The subjects with B2B2 and
B1B2 genotyes in LG had higher HDL-C levels and
HDL-C/LDL-C ratio than the subjects with B1B1 geno-
tye, whereas the B2 allele carriers in non-LG had lower
TC and higher HDL-C levels than the B2 allele noncar-
riers. The levels of HDL-C in LG were different among
the genotypes in males but not in females. The levels of
HDL-C in non-LG were different among the genotypes
in males, whereas the levels of TC, HDL-C and LDL-C
were different among the genotypes in females. The rea-
son for this discrepancy is not well known. Thus, to bet-
ter define the exact association of TaqIB polymorphisms
with serum HDL-C levels and CHD, further studies are
required in large populations.
Conclusion
The current study shows that the genotypic and allelic
frequencies of CETP TaqIB polymorphism were not dif-
ferent between LG and non-LG, but the association of
CETP TaqIB polymorphism and serum lipid profiles is
different between the two groups in the Chinese Bama
Zhuang population. The B2 allele and B2B2 genotype
were associated with high HDL-C levels. Thus, CETP
TaqIB polymorphism might be one of the longevity-
related genes in this population.
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